Investigating imaging network markers of cognitive dysfunction and pharmacoresistance in newly diagnosed epilepsy: a protocol for an observational cohort study in the UK
Introduction Epilepsy is one of the most common serious brain disorders, characterised by seizures that severely affect a person’s quality of life and, frequently, their cognitive and mental health. Although most existing work has examined chronic epilepsy, newly diagnosed patients present a unique...
Saved in:
| Main Authors: | Anthony Guy Marson, Marta García-Fiñana, Christophe de Bézenac, Gus Baker, Perry Moore, Nicola Leek, Rajiv Mohanraj, Leonardo Bonilha, Mark Richardson, Simon Keller |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-10-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/10/e034347.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of vagal nerve stimulation in patients with pharmacoresistant epilepsy
by: I. G. Areshkina, et al.
Published: (2019-04-01) -
The experience of applying vagus nerve stimulation in treatment of pharmacoresistant epilepsy
by: A. A. Shatokhin, et al.
Published: (2023-12-01) -
Notch-1 Immunopositivity in Brain Lesions Associated with Pharmacoresistant Epilepsy
by: Dimitar Metodiev, et al.
Published: (2025-02-01) -
Ketogenic diet in pharmacoresistant epilepsies: a clinical nutritional assessment
by: Cecilia Nascimento de Mendonça, et al.
Published: (2024-02-01) -
EXPERIENCE WITH USE OF CHRONIC NEUROSTIMULATION OF VAGUS NERVE IN TREATMENT OF PHARMACORESISTANT EPILEPSY
by: А. А. Sufianov, et al.
Published: (2016-09-01)